Aims and Scope
EBioMedicine is the premium gold open access venue for translational biomedical research.
The journal is dedicated to publishing original research that elucidates, or aims to modify, disease pathways and mechanisms–with the goal of advancing our knowledge in any biomedical discipline with relevance to human health. Together with EClinicalMedicine, EBioMedicine is part of The Lancet’s open access offering for quality biomedical research.
What we publish
EBioMedicine publishes research papers investigating the basic determinants of human health and disease, the discovery and characterization of new therapeutic targets and treatments, and the identification of biomarkers and diagnostic tools which may help researchers and clinicians better understand and monitor disease. The journal also publishes relevant reviews, commentaries and opinion pieces.
What we cover
We cover the whole spectrum of biomedical research, from preclinical studies with clear human relevance, through to proof-of-concept, first-in-human studies and clinical trials.
Our mission
We aspire to catalyse dialogue and collaboration between basic scientists, clinical researchers and healthcare professionals, enhance the accessibility and applicability of basic research findings for health professionals, and promote a better understanding of clinical challenges for biomedical researchers.
Join our efforts in translating science to improve health!
Submit your paper
